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Introduction: Metacognitive constructs have shown promise in 
explaining the symptoms of Obsessive-Compulsive Disorder (OCD). 
Few studies have examined the role of metacognitions in symptom 
dimensions of OCD, despite mounting clinical, neuropsychological and 
imaging evidence for the distinctiveness of these dimensions.
Methods: Metacognitions were assessed using the Metacognitions 
Questionnaire (MCQ-30) in 51 participants with DSM IV OCD and 46 
healthy controls. The Maudsley Obsessional Compulsive Inventory 
(MOCI) was used to quantify symptom dimensions, along with the 
Hamilton Anxiety Rating Scale (HAM-A) for anxiety, and Hamilton 
Depression Rating Scale (HAM-D) for depression.
Results: Individuals with OCD differed from healthy controls on 
beliefs of uncontrollability and danger when depression and anxiety 
were controlled for. Correlations between metacognitive beliefs and 
obsessive-compulsive symptom dimensions were largely similar across 
the OCD and healthy control groups. Hierarchical regression showed 
that need to control thoughts contributed to checking, cleaning and 
rumination symptoms; cognitive self-consciousness to symptoms of 
slowness; uncontrollability and danger to doubt symptoms; positive 
beliefs to checking symptoms.
Conclusions: Specific associations between metacognitive variables 
and the different symptom dimensions of OCD are evident, however, 
severity of anxiety and depression also contribute to these associations.
Keywords: Metacognitions, obsessive-compulsive disorder, symptom 
dimensions, symptom subtypes, checking, cleaning
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Obsessive compulsive disorder (OCD) is characterized by obsessions, which 
are egodystonic and unwanted thoughts or impulses, and compulsions, 
which are repetitive behaviors or mental acts (1). Metacognition refers 
to the psychological structures, knowledge, events, and processes that 
are involved in the control, modification, and interpretation of thinking 
(2). Given the growing focus on thoughts in OCD, it has been proposed 
that dysfunctional appraisals of intrusive thoughts have an important 
role in the etiology and maintenance of obsessions and compulsions 
(3). Cognitive theories have varied in the emphases placed on the role of 
various aspects of beliefs about thoughts. Wells’ s metacognitive model 
of OCD (3) emphasizes beliefs about the importance and meaning of 
thoughts, the need to control thoughts, and the need to perform rituals 
to prevent dreaded consequences. The metacognitions that are thought 
to be specific to OCD are thought fusion beliefs, beliefs about rituals, and 
stop signals.
Metacognitions that are not specific to any psychiatric disorder can be 
called “generic metacognitions.” Generic metacognitions are general 
metacognitions that can be seen both in OCD and in other psychiatric 
disorders. These metacognitions include beliefs about the usefulness of 
worry, increased focus on one’s thought processes, reduced cognitive 
confidence, and beliefs about the uncontrollability and danger of 
thoughts and need to control thoughts (4). Cognitive interventions 
focused on metacognitive beliefs have shown promise in the treatment 
of OCD (2). However, one of the challenges faced by clinicians over 
the years has been that OCD is a heterogeneous condition, and an 
intervention which is successful for one person may not be suitable for 
another symptom presentation. Evidence has been steadily accumulating 
to support the distinctiveness of symptom dimensions within OCD 
with regard to clinical correlates (5) and neuropsychological (6) and 
neuroimaging findings (7). While a few studies have investigated OCD-
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specific metacognitions, including thought fusion beliefs, beliefs about 
rituals, and internal stop signals (8), generic metacognitive beliefs may 
also be useful in understanding the processes involved in the various 
symptom dimensions of OCD. It is expected that metacognitive 
processes, including obsessive-compulsive (O-C) beliefs, will contribute 
differentially to the symptom dimensions of OCD. Such an understanding 
is anticipated to be useful in improving the effectiveness of individualized 
cognitive-behavioral interventions for different symptom presentations 
in OCD.
Many studies investigating the relationship between metacognition and 
obsessive symptoms in OCD have used non-clinical samples (3, 9), which 
are hypothesized to be analogous to OCD samples in that worry and 
obsessions are normally occurring phenomena; however, the need to 
study clinical samples has been emphasized (9). There is some evidence 
that, in comparison to healthy individuals, individuals with OCD are 
highly aware of their thoughts (10) and believe that they cannot control 
some thoughts, which poses a danger (11).
A handful of studies have focused on relationships between metacognitive 
beliefs and O-C symptom dimensions of OCD patients. Although two of 
these studies have indicated that metacognitive beliefs are related to the 
severity of general symptoms (11), one study indicated no relationship (8). 
Pazvantoğlu et al. studied these relationships, using the Metacognition 
Questionnaire-30 scale to evaluate generic metacognitions and the 
Maudsley Obsessional Compulsive Inventory to evaluate the dimensions 
of O-C symptoms. They reported correlations between doubting and all 
subscales of the Metacognition Questionnaire-30 scale: checking, slowness, 
rumination, and uncontrollability and danger; and checking, slowness, 
rumination, doubt, and cognitive self-consciousness. However, the effects 
of age, gender, and symptoms of depression and anxiety related to 
metacognitions had not been controlled. (12).
There is some evidence suggesting that there may be a greater 
dysfunction in metacognitive beliefs in females than in males, and in 
younger as compared to older individuals (13). Because metacognitive 
beliefs are also known to be affected by anxiety and depression in 
general (3, 14), it would be important to control for these confounding 
factors as well.
In this context, this study focused on investigating the relationship between 
metacognitive constructs and the various symptom dimensions of OCD 
and also on investigating differences and similarities in metacognitions 
related to O-C symptom dimensions between individuals with OCD and 
healthy controls. The hypothesis of this study was to find a relationship 
between metacognitive beliefs and O-C symptoms in both groups after 
controlling the confounding effects.
METHOD
Participants
The present study included 51 individuals with OCD and 46 healthy 
controls aged between 18 and 59 years. Approval from the Pamukkale 
University Medical Faculty Ethics Committee was obtained before the 
study, and the study was carried out in accordance with the Declaration 
of Helsinki. Written informed consent was obtained from patients and 
healthy controls.
Consecutive patients with a diagnosis of OCD who were referred to, or 
followed at, the Anxiety Disorders outpatient clinic formed the clinical 
group. Patients with an intellectual disability, significant neurological 
or medical disorder, psychotic and/or bipolar disorder, or a history of 
alcohol or substance abuse or dependence were excluded from the 
study. The control group consisted of age-, gender-, and education level-
matched hospital staff or their relatives who had no psychopathology as 
determined by the Structured Clinical Interview for the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-IV) (SCID).
Interview and Assessment Tool
Sociodemographic and clinical characteristics of the participants were 
recorded through psychiatric interviews. The SCID (15) was administered 
to all participants to diagnose OCD and other psychiatric disorders. O-C 
symptoms were assessed by category on the Maudsley Obsessional 
Compulsive Inventory (MOCI) (16) and the severity of these symptoms 
in individuals with OCD was assessed using the Yale-Brown Obsessive 
Compulsive Scale (Y-BOCS) (17, 18). The Hamilton Depression Rating 
Scale (HAM-D) (19) and Hamilton Anxiety Rating Scale (HAM-A) (20) 
were used with all participants to assess the severity of depression and 
anxiety symptoms. Thereafter, the Metacognitions Questionnaire (MCQ) 
was administered. An experienced psychiatrist performed the interviews 
and applied the assessment tools.
The Structured Clinical Interview for DSM-IV Axis I Disorders/
Clinical Version (SCID-I/CV)
The SCID is a structured interview tool for diagnosis of Axis I mental 
disorders according to the DSM-IV (15). This tool has been adapted and 
translated into Turkish and is deemed to have satisfactory psychometric 
properties (21).
Maudsley Obsessional Compulsive Inventory
This inventory is a 30-item patient-rated scale to assess the presence 
and extent of O-C symptoms (16). The original scale includes checking, 
cleaning, slowness, and doubting subscales. While the original MOCI 
contains two items on rumination, the Turkish version (22) includes seven 
additional rumination items adapted from the Minnesota Multiphasic 
Personality Inventory.
Yale-Brown Obsessive Compulsive Scale (Y-BOCS)
This scale is a clinician-rated scale to assess the severity of O-C symptoms 
(17, 18). The validity and reliability of the Turkish version have been 
established (23).
Hamilton Depression Rating Scale (HAM-D)
This is a clinician-rated scale to measure the severity of depressive 
symptoms (19) with satisfactory psychometric properties for the Turkish 
version (24).
Hamilton Anxiety Rating Scale (HAM-A)
The HAM-A is a clinician-rated measure of somatic and psychic anxiety 
symptoms (20). The interrater reliability coefficient of the Turkish version 
is reported as 0.94 (25).
Metacognitions Questionnaire (MCQ-30)
The MCQ (26) is a self-report assessing metacognitive beliefs, with higher 
scores indicating stronger beliefs about the negative consequences 
of one’s thoughts. The MCQ has five subscales: positive beliefs about 
worry (e.g., “worrying helps me cope”), cognitive confidence (e.g., 
“I do not trust my memory”), uncontrollability and danger (e.g., “my 
worrying could make me go mad”), cognitive self-consciousness (e.g., 
“I am constantly aware of my thinking”), and need to control thoughts 
(e.g., “if I did not control a worrying thought and then it happened, it 
would be my fault”). Validity and reliability of the Turkish version have 
been established (27).
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Statistical Analysis
The Statistical Package for the Social Sciences (SPSS, Inc., Chicago, IL, USA) 
program, version 15.0 for Windows, was used for the statistical analyses. 
Independent two-group comparisons for numerical variables were 
performed by t-test, whereas chi-square test was used for categorical 
variables. Adjustment was performed using two-way analysis of 
covariance (ANCOVA) test to control the effects of depression and anxiety 
in the subscales of MCQ-30. Although we did not use a strict Bonferroni 
correction, a conservative p value of p≤0.01 was set for univariate analyses 
to reduce the risk of Type I errors. Hierarchical regression analysis 
was used to determine the contribution of metacognitive variables to 
the various symptom dimensions. In order to determine the factors 
that contribute to each O-C symptom dimension in the OCD group, a 
hierarchical regression analysis (backward) was performed, including age, 
gender, HAM-D and HAM-A scores in the first step, and MCQ subscales 
(positive beliefs about worry, cognitive confidence, uncontrollability and 
danger, cognitive self-consciousness, and need to control thoughts) in the 
second step. In this way, the study was aimed to evaluate the relationship 
between O-C symptoms and MCQ-30 subscale scores, which were 
studied after controlling for the effects of age, gender, symptoms of 
depression and anxiety, and other MCQ-30 subtests.
RESULTS
We calculated that when at least 80 samples (40 for each group) were 
included in the study, the result would be 95% power with 95% confidence 
from the results obtained from the reference study (12) for the effect size 
“d=0.748.” We included 51 patients and 46 healthy control subjects. For 
the MCQ-30 total results, we reached 99% power with 95% confidence 
(for an effect size of “d=0.81”).
There were no differences between the OCD and control groups 
regarding age (33.52±10.67 and 33.74±10.04, t=-00.848, p=0.374), male/
female distribution (20/31 and 19/27, χ2=0.044, p=0.834), and years of 
education (11.11±3.54 and 12.00±4.13, t=1.132, p=0.092). The OCD 
group had significantly higher scores than the control group (all p<0.001) 
on HAM-D (7.23±4.07 and 1.71±1.77, respectively), HAM-A (7.43±5.28 
and 1.91±2.06) and total MOCI (23.58±9.31 and 8.41±6.50). In the 
OCD group, the mean Y-BOCS total scores were 17.81±8.27 (obsession 
9.32±4.54, compulsion 8.48±3.99). Eight of the patients were drug-free, 
while 17 were taking selective serotonin reuptake inhibitors (SSRIs), two 
were taking clomipramine, and one was taking venlafaxine. Also, some 
patients were on SSRI + second generation antipsychotics (n=20) and 
clomipramine + second generation antipsychotics (n=3).
Table 2. Correlations of the Metacognitions Questionnaire with the symptom dimensions
MOCI YBOCS
    Checking       Cleaning     Slowness      Doubting    Rumination        Total   Total
MCQ Control OCD Control OCD Control OCD Control OCD Control OCD Control OCD   OCD
Positive beliefs 0.310 0.163 0.217 0.117 0.243 0.195 0.250 0.165 0.412* 0.194 0.393* 0.200   -0.205
Uncontrollability and 
danger
0.267 0.236 0.370 0.403* 0.441* 0.454** 0.375* 0.529** 0.590** 0.620** 0.576** 0.594**   0.163
Cognitive confidence 0.218 0.283* 0.145 0.246 0.221 0.152 0.009 0.228 0.188 0.125 0.171 0.175   0.236
Need to control 
thoughts
0.386* 0.138 0.420* 0.451** 0.338 0.499** 0.407* 0.577** 0.708** 0.686** 0.614** 0.678**   0.283
Cognitive self-
consciousness
0.358 0.181 0.430* 0.287 0.302 0.568** 0.329 0.529** 0.535** 0.614** 0.556** 0.597**   0.138
MCQ-Total 0.392* 0.525** 0.405* 0.462** 0.391* 0.546** 0.347 0.604** 0.607** 0.613** 0.572** 0.649**   0.181
OCD, Obsessive-Compulsive Disorder; MOCI, Maudsley Obsessional Compulsive Inventory; YBOCS,  Yale-Brown Obsessive Compulsive Scale; MCQ, Metacognitions 
Questionnaire.
*p<0.01, **p<0.001
Table 1. Scores of the Metacognitions Questionnaire-30 in the study groups
Control Group 
(n=46)
OCD Group 
(n=51) t df
p
Controlling for HAM-D and 
HAM-A (ANCOVA)
F df p
Mean±SD (Range) Mean±SD (Range)
Positive beliefs 12.35±4.50 (6-21) 12.41±4.80 (6-24) -0.067 95 0.946 1.347 1 0.249
Uncontrollability and danger 10.87±3.89 (5-21) 15.98±4.31 (6-24) -6.098 95 <0.001 5.941 1 0.017
Cognitive confidence 12.59±4.80 (6-24) 14.88±5.27 (6-24) -2.234 95 0.028 0.070 1 0.792
Need to control thoughts 11.78±4.79 (6-23) 16.98±5.10 (6-24) -5.152 95 <0.001 2.971 1 0.088
Cognitive self-consciousness 16.35±4.87 (7-27) 17.66±4.45 (5-24) -1.392 95 0.167 0.548 1 0.461
Total 63.93±17.85(33-94) 77.98±16.67 (34-106) -4.00 95 <0.001 0.393 1 0.532
OCD, obsessive-compulsive disorder; HAM-D, the Hamilton Depression Rating Scale; HAM-A, the Hamilton Anxiety Rating Scale; ANCOVA, analysis of covariance.
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According to the scores on the MCQ-30, the MCQ-uncontrollability and 
danger,-cognitive confidence,-need to control thoughts, and-total scores 
were significantly higher in the OCD group than in the control group 
(Table 1). When the total scores of HAM-D and HAM-A scales were 
used as covariates, the MCQ-uncontrollability and danger score was 
significantly higher in the OCD group. The correlations of MCQ scores 
with the MOCI and Y-BOCS scores are shown in Table 2. Although there 
were some differences, the pattern of correlations in the OCD group was 
similar to the control group. Hierarchical regression analysis indicated 
relationships between checking and positive beliefs and need to control 
thoughts; cleaning and need to control thoughts; slowness and cognitive 
self-consciousness; doubt and uncontrollability and danger; and rumination 
and need to control thoughts (Table 3).
DISCUSSION
The present study compared OCD patients with healthy controls in terms 
of metacognitive beliefs and investigated the relation of dysfunctional 
metacognitive beliefs to O-C symptoms.
Previous studies have viewed metacognitions in healthy controls as 
analogous to those in individuals with OCD (9). Current results support 
this conceptualization; nevertheless, individuals with OCD in the present 
study differed from controls mainly in metacognitive beliefs relating 
to uncontrollability and danger. This subscale has been demonstrated 
to be the most successful in differentiating individuals with OCD from 
controls and non-anxious patients from controls (4), although there 
were no significant differences in comparison with a panic disorder 
group (11). In this study, the beliefs in uncontrollability and danger were 
associated with doubt symptoms. Likewise, metacognitions relating 
to uncontrollability and danger have been found to be correlated with 
indecisiveness in OCD (11).
An important result of the current study was to find the relationship 
of metacognitive beliefs of need to control thoughts to symptoms of 
checking, cleaning, and rumination. The present findings corroborate 
with cognitive theories of OCD that posit a significant role in the meaning 
and importance attached to random thoughts in the development and 
maintenance of obsessions and compulsions (3). In other words, normal 
intrusions are elevated to obsessions when individuals perceive them as 
dangerous or unacceptable. These individuals believe themselves to be 
responsible for the dreaded consequences or that having a thought of 
the event equates to the action occurring in reality (3). This belief results 
in a strong urge to control the thought, either by attempting to block 
it or performing a neutralizing compulsion. According to these findings, 
metacognitive therapy focused on need to control thoughts can be benefit 
for a large proportion of OCD patients.
Table 3. Hierarchical regression analyses in OCD group (dependent variables were MOCI subscales, and predictors were age, gender, HAM-D and 
HAM-A scores in the first step, and MCQ subscales in second step). 
B SE Beta t p
Checking R2=0.286
Constant -0.541 1.146 - -0.472 0.639
Positive beliefs 0.157 0.060 0.325 2.630 0.011
Need to control thoughts 0.171 0.056 0.377 3.054 0.004
Cleaning R2=0.327
Constant 0.580 1.441 - 0.403 0.689
HAM-A Total 0.164 0.057 0.361 2.875 0.006
Age 0.052 0.027 0.234 1.932 0.059
Need to control thoughts 0.143 0.059 0.305 2.401 0.020
Slowness R2=0.229
Constant -0.236 0.965 - -0.244 0.808
Cognitive self consciousness 0.252 0.053 0.478 3.811 0.000
Doubt R2=0.347
Constant 2.785 1.047 - 2.659 0.011
Gender -0.933 0.416 -0.265 -2.244 -0.030
Uncontrollability and danger 0.194 0.047 0.484 4.089 0.000
Rumination R2=0.522
Constant 1.506 1.449 - 1.039 0.304
HAM-D 0.211 0.075 0.320 2.817 0.007
Gender -1.465 0.564 -0.268 -2.597 0.013
Positive beliefs 0.099 0.058 0.176 1.700 0.096
Need to control thoughts 0.190 0.060 0.361 3.161 0.003
MOCI, Maudsley Obsessional Compulsive Inventory; HAM-A, the Hamilton Anxiety Rating Scale; HAM-D, the Hamilton Depression Rating Scale.
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Our study also demonstrated a relationship between beliefs of cognitive 
self-consciousness and slowness symptoms. A previous study (11) found 
a correlation between cognitive self-consciousness and indecisiveness. 
Intuitively, it seems likely that a constant focus directed toward one’s 
thoughts, as assessed for cognitive self-consciousness, would contribute 
to indecision and slowness by increasing the cognitive system load 
and inefficient processing of material that would otherwise be 
processed non-consciously. Another result of the current study was that 
metacognitive beliefs of positive beliefs about worry were associated with 
checking symptoms. This finding has also been reported by a previous 
study of a sub-clinical sample (3). It has been proposed that checking 
symptoms may represent a way to avoid anxiety about the future (28). 
In this context, it seems natural that individuals who have strong beliefs 
about the usefulness of worry also use checking symptoms as a way to 
anticipate and avoid danger in the future.
The patterns of association between metacognitive scales and O-C 
symptoms were largely similar across the OCD and control samples, a 
finding that corresponds to another study (29). That study indicated that 
the metacognitive domains of thought fusion beliefs and beliefs about 
rituals were correlated with O-C symptoms in an OCD sample and a 
community sample. In the present study, the strength of associations 
between metacognitive variables and O-C symptoms was greater for 
the OCD group. Healthy controls differ from individuals with OCD 
primarily in the association of positive beliefs about worry with normally 
occurring O-C symptoms. The positive beliefs about worry subscale has 
also appeared in previous research as normal or mildly dysfunctional in 
individuals with OCD (4, 11).
Only a handful of studies have investigated the relationship between 
metacognitions and O-C symptom dimensions in OCD patients. 
Differences in emphasis on metacognitive variables, coupled with 
variations in definition and assessment of the specific symptom 
dimensions, make it difficult to compare findings across studies reliably. 
There are many limitations of this study. One limitation is an exclusive 
reliance on the Metacognitions Questionnaire to assess metacognitions 
in OCD, where other instruments used in conjunction may have helped 
to provide additional information. Other limitations include a sampling 
of patients on medications, given that SSRIs have previously been 
reported to reduce dysfunctional metacognitive beliefs (30). The effects 
of medication on metacognitive beliefs in OCD need to be investigated 
further. Also, the sample size of the OCD group was small. Therefore, 
the findings of this study need to be confirmed in larger samples. The 
final limitations of this study were that clinical insight, subsyndromal 
psychotic features, and response to treatment in patients were not 
evaluated. These clinical properties can be related to metacognitive 
beliefs.
Specific associations between metacognitive variables and the different 
symptom dimensions of OCD are evident. However, the severity of 
anxiety and depression also contributes to these associations. Further 
studies that assess a comprehensive range of metacognitive beliefs, along 
with neuropsychological and imaging indices, will contribute significantly 
to an integrative understanding of the factors underpinning the different 
symptom presentations of OCD, which is expected to enhance the 
development of specific and effective cognitive interventions.
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